Related Experiment Video
Updated: Jul 13, 2026
11:47
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Inconsistency of reported uremic toxin concentrations
Natalie Meert1, Eva Schepers, Rita De Smet
1The Nephrology Section, Department of Internal Medicine, University Hospital, Gent, Belgium.
Artificial Organs
|July 27, 2007
Summary
This study analyzed uremic toxin concentrations from 378 publications, finding significant discrepancies in reported data for many retention solutes. Refined guidelines are needed for interpreting highly variable uremic toxin levels.
Area of Science:
- Biochemistry
- Nephrology
- Analytical Chemistry
Background:
- Uremic toxins are key indicators of chronic kidney disease progression.
- Variability in reported concentrations complicates clinical interpretation and research.
Purpose of the Study:
- To systematically evaluate discrepancies in reported concentrations of 78 uremic retention solutes.
- To identify solutes with high variability and assess data homogeneity.
Main Methods:
- Screened 378 publications, retaining up to eight per toxin.
- Calculated highest-to-lowest (H/L) and highest-to-median (H/M) concentration ratios.
- Categorized 78 solutes into three groups based on H/L ratios.
Main Results:
- Solutes in Groups A (H/L < 3) and B (3 < H/L < 8.5) showed low to intermediate scatter, indicating data homogeneity.
- Group C (H/L > 8.5) exhibited substantial scatter, with at least 10 compounds showing extremely divergent concentrations (H/M > 5.5).
- Highest reported concentrations are suitable references for Group A and B solutes.
Conclusions:
- Significant variability exists in reported uremic toxin concentrations, particularly for Group C solutes.
- Refined directives are necessary for interpreting highly divergent data, especially for Group C and scatter-analyzed compounds.
- Standardizing reporting and analysis methods is crucial for reliable uremic toxin assessment.
Related Concept Videos
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...